Caterina Vivaldi

azienda ospedaliero-universitaria pisana

H指数:32

被引数:3,645

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Stratifying Cardiovascular Risk in Patients With HCC Receiving Atezolizumab/Bevacizumab: A Comparison of ESC and CARDIOSOR Scores

在采用阿替利珠单抗/贝伐珠单抗治疗的肝癌患者中分层心血管风险：ESC评分与CARDIOSOR评分的比较

Liver International

IF5.2

2026-10-070

OAAI

Bernardo Stefanini; Lorenza Rimassa; Massimo Iavarone; Giuseppe Cabibbo; Fabio Marra; Caterina Vivaldi; Andrea Dalbeni; Francesca Romana Ponziani; Andrea Palloni; Sara Lonardi; Lorenzo Lani; Piera Federico; Gianluca Svegliati-Baroni; Tiziana Pressiani; Luca Ielasi; Chiara Mazzarelli; Stefania De Lorenzo; Rodolfo Sacco; Mariangela Bruccoleri; Ciro Celsa; Alessio Mastro; Gianluca Masi; Alessandra Auriemma; Leonardo Stella; Pierluigi Toniutto; Rosanna Villani; Chiara Deiana; Sara Ascari; Mariarosaria Marseglia; Alessandro Granito; Fabio Piscaglia; Francesco Tovoli; the ARTE Study Group

Prognostic stratification of patients with biliary tract cancer treated with chemoimmunotherapy: A retrospective multicenter real-world study

胆道癌患者接受化疗免疫疗法后的预后分层：一项回顾性多中心真实世界研究

Cancer

IF5.1

2026-09-160

PRE

Mara Persano MD; Andrea Casadei-Gardini MD; Lorenzo Fornaro MD; Tomoyuki Satake MD, PhD; Oluseyi Abidoye MD; Federica Lo Prinzi MD; Lorenzo Antonuzzo MD; Jin Won Kim MD, PhD; Francesca Bergamo MD; Melanie Bathon MD; Anna Saborowski MD; Tiziana Pressiani MD; Caterina Vivaldi MD; Ilario Giovanni Rapposelli MD; Frederik Peeters MD; Chiara Braconi MD, PhD; David J. Pinato MD, PhD; Emiliano Tamburini MD; Monica Niger MD; Stefano Tamberi MD; Florian Castet MD; Monica Verrico MD; Alessandro Parisi MD; Nuno Couto MD; Hong Jae Chon MD, PhD; Angela Lamarca MD, PhD; Guido Giordano MD; Fabian Finkelmeier MD; Ester Oneda MD; Antonio Avallone MD; Lukas Perkhofer MD; Il Hwan Kim MD, PhD; Ingrid Garajova MD; Salvatore Corallo MD; Elisabetta Fenocchio MD; Emanuela Dell’Aquila MD; Chiara Pirrone MD; Lorenzo Lucidi MD; Giulia Tesini MD; Elena Valenzi MD; Anna Diana MD; Changhoon Yoo MD, PhD; Marta Schirripa MD; Vincenzo Formica MD; Maria Grazia Rodriquenz MD; Mario Scartozzi MD; Jorge Adeva MD; Michele Ghidini MD; Gerald W. Prager MD; Giuseppe Aprile MD; Gian Paolo Spinelli MD; Su Yung-Yeh MD, PhD; Stephen L. Chan MD; Masafumi Ikeda MD; Tanios Bekaii-Saab MD; Jessica Lucchetti MD; Daniele Lavacchi MD; Minsu Kang MD; Rita Balsano MD; Francesca Salani MD; Silvia Camera MD; Gianluca Masi MD; Sara Lonardi MD; Arndt Vogel MD, PhD; Lorenza Rimassa MD; Margherita Rimini MD

Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy

胆道癌患者接受化疗免疫疗法治疗后不良事件预测作用的全球人群研究

Cancers

IF4.4

2026-09-100

Linda Bartalini; Margherita Rimini; Masafumi Ikeda; Oluseyi Abidoye; Jessica Lucchetti; Lorenzo Antonuzzo; Jin Won Kim; Arndt Vogel; Angela Lamarca; Federico Nichetti; Anna Saborowski; Tiziana Pressiani; Caterina Vivaldi; Ilario Giovanni Rapposelli; Jeroen Dekervel; Chiara Braconi; David James Pinato; Emiliano Tamburini; Chiara Carlotta Pircher; Stefano Tamberi; Florian Castet; Monica Verrico; Alessandro Parisi; Nuno Couto; Hong Jae Chon; Andrea Martirena; Matteo Landriscina; Fabian Finkelmeier; Ester Oneda; Antonio Avallone; Emanuela Dell’Aquila; Lukas Perkhofer; Il Hwan Kim; Vincenzo Formica; Cidalia Maria de Sousa Pinto; Ingrid Garajova; Beodeul Kang; Salvatore Corallo; Elisabetta Fenocchio; Giovanni Farinea; Alessandro Pastorino; Anna Diana; Changhoon Yoo; Marta Schirripa; Maria Grazia Rodriquenz; Mario Scartozzi; Lucrezia Zumstein; Michele Ghidini; Gerald W. Prager; Giuseppe Aprile; Gian Paolo Spinelli; Yung-Yeh Su; Stephen L. Chan; Emily Warmington; Alessia Lancianese; Tomoyuki Satake; Tanios Bekaii-Saab; Daniele Lavacchi; Laura Passeri; Michele Ferrara; Minsu Kang; Alessandra Anna Prete; Silvia Bozzarelli; Mara Persano; Andrea Pretta; Gianluca Masi; Rita Balsano; Monica Niger; Sara Lonardi; Francesca Salani; Silvia Camera; Lorenzo Fornaro; Andrea Casadei-Gardini; Lorenza Rimassa

Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ-1 Study Eligibility: A Large Global Analysis in a Real-World Setting

根据TOPAZ-1研究入组标准评估顺铂、吉西他滨和度伐利尤单抗的疗效：一项真实世界环境下的全球性大规模分析

International Journal of Cancer

IF4.7

2026-08-160

PRE

Federica Lo Prinzi; Margherita Rimini; Masafumi Ikeda; Oluseyi Abidoye; Jessica Lucchetti; Lorenzo Antonuzzo; Jin Won Kim; Federico Nichetti; Anna Saborowski; Tiziana Pressiani; Caterina Vivaldi; Ilario Giovanni Rapposelli; Frederik Peeters; Chiara Braconi; David J. Pinato; Emiliano Tamburini; Chiara Pircher; Stefano Tamberi; Florian Castet; Monica Verrico; Alessandro Parisi; Nuno Couto; Hong Jae Chon; Andrea Martirena; Angela Lamarca; Matteo Landriscina; Fabian Finkelmeier; Ester Oneda; Antonio Avallone; Emanuela Dell'Aquila; Lukas Perkhofer; Il Hwan Kim; Vincenzo Formica; Cidalia Maria de Sousa Pinto; Ingrid Garajova; Beodeul Kang; Salvatore Corallo; Elisabetta Fenocchio; Giovanni Farinea; Alessandro Pastorino; Anna Diana; Yoo Changhoon; Marta Schirripa; Maria Grazia Rodriquenz; Mario Scartozzi; Lucrezia Zumstein; Michele Ghidini; Gerald W. Prager; Giuseppe Aprile; Gian Paolo Spinelli; Su Yung-Yeh; Stephen Lam Chan; Emily Warmington; Alessia Lancianese; Tomoyuki Satake; Tanios Bekaii-Saab; Guido Giordano; Daniele Lavacchi; Laura Passeri; Michele Ferrara; Minsu Kang; Alessandra Anna Prete; Silvia Bozzarelli; Mara Persano; Gianluca Masi; Rita Balsano; Monica Niger; Sara Lonardi; Francesca Salani; Silvia Camera; Arndt Vogel; Lorenzo Fornaro; Lorenza Rimassa; Andrea Casadei-Gardini

Exploring the Role of Surgery After Systemic Therapy in Locally Advanced Biliary Tract Cancer: Outcomes From a Large Retrospective Multinational Real-World Cohort Treated With Cisplatin, Gemcitabine, and Durvalumab

探索系统性治疗后的手术治疗在局部晚期胆道癌中的作用：来自接受顺铂、吉西他滨和度伐利尤单抗治疗的大型回顾性跨国真实世界队列的结局

International Journal of Cancer

IF4.7

2026-08-150

PRE

Margherita Rimini; Angela Lamarca; Masafumi Ikeda; Oluseyi Abidoye; Jessica Lucchetti; Lorenzo Antonuzzo; Jin Won Kim; Arndt Vogel; Federico Nichetti; Anna Saborowski; Tiziana Pressiani; Caterina Vivaldi; Ilario Giovanni Rapposelli; Frederik Peeters; Chiara Braconi; David J. Pinato; Emiliano Tamburini; Chiara Pircher; Stefano Tamberi; Florian Castet; Monica Verrico; Alessandro Parisi; Nuno Couto; Hong Jae Chon; Andrea Martirena; Matteo Landriscina; Fabian Finkelmeier; Ester Oneda; Antonio Avallone; Emanuela Dell'Aquila; Lukas Perkhofer; Il Hwan Kim; Vincenzo Formica; Cidalia Maria de Sousa Pinto; Ingrid Garajova; Beodeul Kang; Salvatore Corallo; Elisabetta Fenocchio; Giovanni Farinea; Alessandro Pastorino; Anna Diana; Yoo Changhoon; Marta Schirripa; Maria Grazia Rodriquenz; Mario Scartozzi; Lucrezia Zumstein; Michele Ghidini; Gerald W. Prager; Giuseppe Aprile; Gian Paolo Spinelli; Su Yung-Yeh; Stephen L. Chan; Iakov Bolnykh; Alessia Lancianese; Tomoyuki Satake; Tanios Bekaii-Saab; Daniele Lavacchi; Laura Passeri; Michele Ferrara; Minsu Kang; Massimo Giuseppe Viola; Silvia Bozzarelli; Mara Persano; Gianluca Masi; Rita Balsano; Monica Niger; Sara Lonardi; Francesca Salani; Silvia Camera; Francesca Ratti; Lorenzo Fornaro; Lorenza Rimassa; Andrea Casadei-Gardini

Predicting decompensation in unresectable hepatocellular carcinoma on atezolizumab plus bevacizumab: the ARTE Score

预测阿替利珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌患者的失代偿：ARTE评分

Clinical Gastroenterology and Hepatology

IF12

2026-05-260

PRE

Reproducibility of segmentation and radiomic features in contrast-enhanced CT images of early, intermediate and advanced HCC patients: a multicenter study

早期、中期和晚期肝癌患者增强CT图像中分割和放射组学特征的可重复性：一项多中心研究

European Journal of Radiology

IF3.3

2026-04-260

PRE

Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab

接受顺铂、吉西他滨和度鲁特韦治疗的胆道癌患者中，转移部位对预后的影响

Targeted Oncology

IF4

2026-02-270

PRE

Silvia Camera; Lorenzo Fornaro; Margherita Rimini; Mara Persano; Mario Domenico Rizzato; Anna Saborowski; Lorenzo Antonuzzo; Federico Rossari; Tomoyuki Satake; Frederik Peeters; Francesca Salani; Silvia Bozzarelli; Salvatore Corallo; Jessica Lucchetti; Jin Won Kim; Oluseyi Abidoye; Ilario Giovanni Rapposelli; Chiara Gallio; Stefano Tamberi; Fabian Finkelmeier; Guido Giordano; Pircher Chiara; Hong Jae Chon; Chiara Braconi; Aitzaz Qaisar; Alessandro Pastorino; Florian Castet; Emiliano Tamburini; Changhoon Yoo; Alessandro Parisi; Anna Diana; Mario Scartozzi; Gerald W. Prager; Antonio Avallone; Marta Schirripa; Il Hwan Kim; Lukas Perkhofer; Ester Oneda; Monica Verrico; Nuno Couto; Jorge Adeva; Stephen L. Chan; Gian Paolo Spinelli; Nicola Personeni; Ingrid Garajova; Maria Grazia Rodriquenz; Silvana Leo; Cecilia Melo Alvim; Ricardo Roque; Giovanni Farinea; Virginia Genovesi; Antonio De Rosa; Daniele Lavacchi; Federica Lo Prinzi; Laura Passeri; Michele Ferrara; Silvia Foti; Masafumi Ikeda; Jeroen Dekervel; Monica Niger; Rita Balsano; Giuseppe Tonini; Minsu Kang; Giulia Tesini; Luca Esposito; Chiara Casadio; Vera Himmelsbach; Matteo Landriscina; Selma Ahcene Djaballah; Tanios Bekaii-Saab; Gianluca Masi; Arndt Vogel; Sara Lonardi; Caterina Vivaldi; Lorenza Rimassa; Andrea Casadei-Gardini

Sequential or upfront triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma: the MONTBLANC trial protocol (AIO-HEP-0325/ass)

序贯或 upfront 三联疗法（durvalumab、tremelimumab 和 bevacizumab）用于不可切除的肝细胞癌患者的方案：MONTBLANC 试验方案（AIO-HEP-0325/ass）

Therapeutic Advances in Medical Oncology

IF4.2

2026-02-200

PRE

Najib Ben Khaled; Ursula Ehmer; Ilja Kubisch; Maria A. Gonzalez-Carmona; Alexander Philipp; Max Seidensticker; Julia Altenhofer; Marion Basch; Tim Hüwer; Bettina Oehrle; Andreas Geier; Caterina Soldà; Alessandra Auriemma; Ulrike Bauer; Taotao Zhou; Lukas Perkhofer; Jack Chater; Arndt Weinmann; Johann von Felden; Antonio De Rosa; Caterina Vivaldi; Ignazio Piseddu; Isabel Schwald; Stefan Enssle; Monika Karin; Julia S. Schneider; Moritz N. Gröper; Katarina Ondrejkova; Lena Weiss; Georg Beyer; Kornelius Schulze; Lorenzo Antonuzzo; Gianluca Masi; Bruno Daniele; Jens Ricke; Julia Mayerle; Friedrich Foerster; Florian P. Reiter; Thomas J. Ettrich; Enrico N. De Toni

FOLFOX Versus FOLFIRI as Second-Line Chemotherapy in Patients With Advanced Biliary Tract Cancers: A Multicenter, Italian Study

LIVER INTERNATIONAL

IF5.2

2025-12-300

PRE

Molecular profiling and matched targeted treatment in cholangiocarcinoma: results from the Italian dataset (ANITA)

胆管癌的分子谱分析和匹配的靶向治疗: 来自意大利数据集 (ANITA) 的结果

Journal of Hepatology

IF33

2025-12-270

OAAI

A phase III randomized clinical trial of Gemcitabine and Nab-Paclitaxel as switch maintenance versus continuation of modified FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: The PANThEON Study

一项关于吉西他滨和 Nab-Paclitaxel 作为换用维持治疗 versus 改良 FOLFIRINOX 作为一线化疗在晚期胰腺癌患者中的随机 III 期临床试验：PANThEON 研究

Digestive and Liver Disease

IF3.8

2025-11-280

PRE

Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: results of the DT-real study

在临床实践中，durvalumab联合或单药使用tremelimumab治疗肝细胞癌的可重复安全性及有效性：DT-real研究结果

JHEP Reports

IF7.5

2025-11-200

OAAI

Durvalumab in Advanced Biliary Tract Cancer: Real-World Data From a Large Cohort of Patients Across Multiple International Centers

度伐利尤单抗在晚期胆道癌中的应用：来自多个国际中心大型患者队列的真实世界数据

LIVER INTERNATIONAL

IF5.2

2025-11-120

OAAI

Rimini, Margherita; Fornaro, Lorenzo; Ikeda, Masafumi; Abidoye, Oluseyi; Lucchetti, Jessica; Antonuzzo, Lorenzo; Kim, Jin Won; Nichetti, Federico; Saborowski, Anna; Pressiani, Tiziana; Vivaldi, Caterina; Rapposelli, Ilario Giovanni; Peeters, Frederik; Braconi, Chiara; Pinato, David J.; Tamburini, Emiliano; Pircher, Chiara; Tamberi, Stefano; Castet, Florian; Verrico, Monica; Parisi, Alessandro; Couto, Nuno; Chon, Hong Jae; Martirena, Andrea; Lamarca, Angela; Landriscina, Matteo; Fimkelmeier, Fabian; Oneda, Ester; Avallone, Antonio; Dell'Aquila, Emanuela; Perkhofer, Lukas; Kim, Il Hwan; Pinto, Cidalia Maria de Sousa; Garajova, Ingrid; Kang, Beodeul; Corallo, Salvatore; Fenocchio, Elisabetta; Farinea, Giovanni; Pastorino, Alessandro; Diana, Anna; Changhoon, Yoo; Schirripa, Marta; Rodriquenz, Maria Grazia; Scartozzi, Mario; Zumstein, Lucrezia; Ghidini, Michele; Prager, Gerald W.; Aprile, Giuseppe; Spinelli, Gian Paolo; Yung-Yeh, Su; Chan, Stephen; Warmington, Emily; Lancianese, Alessia; Bekaii-saab, Tanios; Lavacchi, Daniele; Kang, Minsu; Lonardi, Sara; Vogel, Arndt; Prete, Alessandra Anna; Bozzarelli, Silvia; Salani, Francesca; Persano, Mara; Masi, Gianluca; Balsano, Rita; Niger, Monica; Camera, Silvia; Passeri, Laura; Ferrara, Michele; Satake, Tomoyuki; Rimassa, Lorenza; Casadei-Gardini, Andrea

Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine–nab-paclitaxel failure: a propensity score-matched analysis

二线5-FU联合纳米脂质体伊立替康与FOLFOX/XELOX方案对比：在吉西他滨–白蛋白结合型紫杉醇治疗失败后的转移性胰腺癌中的倾向性评分匹配分析

ESMO Open

IF8.3

2025-11-070

OAAI

Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi-Center Real-World Study

仑伐替尼与索拉非尼在肝移植后复发性HCC中的疗效与安全性比较：一项多中心真实世界研究

HEPATOLOGY RESEARCH

IF3.4

2025-11-010

PRE

Lo Prinzi, Federica; Rossari, Federico; De Rosa, Antonio; Vivaldi, Caterina; Kudo, Masatoshi; Shimose, Shigeo; Suda, Goki; Camera, Silvia; Foti, Silvia; Rizzato, Mario Domenico; Salani, Francesca; Nishida, Naoshi; Shirono, Tomotake; Sakamoto, Naoya; Passeri, Laura; Ferrara, Michele; Solda, Caterina; Cesario, Silvia; Ueshima, Kazuomi; Niizeki, Takashi; Sho, Takuya; Persano, Mara; Vitiello, Francesco; Invernizzi, Federica; Lonardi, Sara; Masi, Gianluca; Rimini, Margherita; Gardini, Andrea Casadei

Genomic Pathway Alterations and Their Prognostic Impact in Biliary Tract Cancer: Insights from a Multinational Cohort Treated with Cisplatin, Gemcitabine, and Durvalumab

基因组通路改变及其在胆道癌中的预后影响：来自接受顺铂、吉西他滨和度伐利尤单抗治疗的跨国队列的见解

European Journal of Cancer

IF7.1

2025-10-030

PRE

Chiara Pirrone; Umberto Malapelle; Francesco Pepe; Federica Lo Prinzi; Federico Nichetti; Anna Saborowski; Lorenzo Antonuzzo; Silvia Camera; Tomoyuki Satake; Frederik Peeters; Caterina Vivaldi; Tiziana Pressiani; Jessica Lucchetti; Jin Won Kim; Oluseyi Abidoye; Ilario Giovanni Rapposelli; Stefano Tamberi; Fabian Finkelmeier; Guido Giordano; Chiara Pircher; Hong Jae Chon; Chiara Braconi; Aitzaz Qaisar; Alessandro Pastorino; Florian Castet; Emiliano Tamburini; Changhoon Yoo; Alessandro Parisi; Anna Diana; Mario Scartozzi; Gerald W. Prager; Antonio Avallone; Salvatore Corallo; Marta Schirripa; Il Hwan Kim; Lukas Perkhofer; Ester Oneda; Monica Verrico; Jorge Adeva; Stephen L. Chan; Gian Paolo Spinelli; Nicola Personeni; Ingrid Garajova; Maria Grazia Rodriquenz; Silvana Leo; Cecilia Melo Alvim; Ricardo Roque; Giovanni Farinea; Francesca Salani; Caterina De Grandis; Daniele Lavacchi; Mara Persano; Masafumi Ikeda; Jeroen Dekervel; Monica Niger; Rita Balsano; Giuseppe Tonini; Minsu Kang; Tanios Bekaii-Saab; Luca Esposito; Alessandra Boccaccino; Vera Himmelsbach; Matteo Landriscina; Francesco De Cobelli; Francesca Ratti; Francesca Daniel; Giulia Tesini; Gianluca Masi; Arndt Vogel; Sara Lonardi; Margherita Rimini; Lorenzo Fornaro; Lorenza Rimassa; Andrea Casadei-Gardini

The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population

接受顺铂、吉西他滨和度伐利尤单抗治疗的晚期胆道癌患者中分子改变的影响：一项大型、真实世界、全球性人群研究

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2025-09-011

PRE

Rimini, Margherita; Fornaro, Lorenzo; Lo Prinzi, Federica; Rizzato, Mario Domenico; Saborowski, Anna; Antonuzzo, Lorenzo; Rossari, Federico; Satake, Tomoyuki; Peeters, Frederik; Vivaldi, Caterina; Pressiani, Tiziana; Lucchetti, Jessica; Kim, Jin Won; Abidoye, Oluseyi; Rapposelli, Ilario Giovanni; Tamberi, Stefano; Finkelmeier, Fabian; Giordano, Guido; Nichetti, Federico; Jae Chon, Hong; Braconi, Chiara; Qaisar, Aitzaz; Pirrone, Chiara; Castet, Florian; Tamburini, Emiliano; Yoo, Changhoon; Parisi, Alessandro; Diana, Anna; Scartozzi, Mario; Prager, Gerald W.; Avallone, Antonio; Corallo, Salvatore; Schirripa, Marta; Kim, Il Hwan; Perkhofer, Lukas; Oneda, Ester; Verrico, Monica; Adeva, Jorge; Chan, Stephen L.; Spinelli, Gian Paolo; Personeni, Nicola; Garajova, Ingrid; Rodriquenz, Maria Grazia; Leo, Silvana; Alvim, Cecilia Melo; Roque, Ricardo; Farinea, Giovanni; Salani, Francesca; De Rosa, Antonio; Lavacchi, Daniele; Camera, Silvia; Ikeda, Masafumi; Dekervel, Jeroen; Niger, Monica; Balsano, Rita; Tonini, Giuseppe; Kang, Minsu; Bekaii-Saab, Tanios; Esposito, Luca; Boccaccino, Alessandra; Himmelsbach, Vera; Landriscina, Matteo; Djaballah, Selma Ahcene; Zanuso, Valentina; Malapelle, Umberto; Pepe, Francesco; Masi, Gianluca; Vogel, Arndt; Lonardi, Sara; Rimassa, Lorenza; Casadei-Gardini, Andrea

Advancements in immunotherapy for hepatocellular carcinoma

免疫疗法在肝细胞癌中的进展

EXPERT REVIEW OF ANTICANCER THERAPY

IF2.8

2025-02-061

PRE

Efficacy and safety of atezolizumab/bevacizumab for hepatocellular carcinoma in a real-life prospective cohort: A 2024 update

DIGESTIVE AND LIVER DISEASE

IF3.8

2025-02-010

PRE

Caterina Vivaldi

个人简介

教育背景

工作经历

荣誉奖项

研究方向